TEAHAT2016-11-29T16:17:59+00:00

TEAHAT 

CARDIOLOGY

A clinical trial which asked whether recombinant tissue-type plasminogen activator–rtPA is effective in the presence of optimal therapy–e.g., metoprolol.

Conclusion Patients receiving metoprolol before hospitalisation had smaller infarcts; beta blockade and thrombolytics have an additive cardioprotective effect due to decreased cardiac work and metabolic demand and improved perfusion via the coronary arteries. 

Abbreviation for Thrombolysis Early in Acute Heart Attack Trial

Reference Advances in Non-Invasive Electrocardiographic Monitoring Techniques, HH Osterhues, H Vinzenz Hombach, AJ Moss; Springer, 2000 

Leave A Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.